Index | Parent Index | Build Freedom: Archive

Hypericum & Depression

Previous  |  Contents  |  Next

The Good News
Now that we've covered the basics, we can discuss the good news about hypericum and depression.

In a nutshell: Medical research has shown that hypericum is an effective treatment for depression -- as successful as prescription antidepressants in the majority of patients.

The medical studies show that from fifty to eighty percent of depressed patients have a significant decrease in the symptoms of depression and a corresponding increase in well-being. This success rate is the same as that of prescription antidepressants.

Unlike prescription antidepressants, however, (a) the side effects of hypericum are few and mild, (b) hypericum costs considerably less, and (c) hypericum is available without a prescription.

Hypericum opens whole new avenues of treatment for the eighteen million people in this country who have depression -- especially the twelve million who are not currently receiving any treatment whatsoever.

Hypericum is the most extensively researched and used herbal antidepressant known. Over 5,000 patients have participated in drug-monitoring studies -- more than 2,000 of these in double-blind studies. Eight head-to-head comparisons showed hypericum was as effective as prescription antidepressants, but with fewer side effects. More than twenty million people in Germany regularly take hypericum for depression.

The high success rate of treatment -- combined with hypericum's minimal side effects, low cost, and availability -- make hypericum, for many people, the first line of treatment for long-term low-grade depression and for mild to moderate major depression.

This section of the book explores this good news. Let's begin by exploring the side effects of hypericum.


Copyright © 1996 by Harold H. Bloomfield, M.D. and Peter McWilliams

Previous  |  Contents  |  Next


Index | Parent Index | Build Freedom: Archive

Disclaimer - Copyright - Contact

Online: buildfreedom.org | terrorcrat.com / terroristbureaucrat.com